The partnership will involve RIKEN’s expertise in bioengineering and image data manipulation and ZEISS’ leadership in optical solutions to facilitate in the development of technologies in bioengineering and bring about a paradigm change in health care.
Dr. Stefan Sacré, Head of ZEISS in Japan commented: “We are proud to complement RIKEN’s broad-spectrum and extensive basic research through our expertise in biomedical imaging, which we see as a fundamental ingredient for turning bioengineering into viable healthcare solutions. The success of leading-edge research requires not only groundbreaking ideas but also access and management of advanced scientific equipment. Highest level of instrument availability and advanced image data management are key to efficient R&D.”
RIKEN and ZEISS partnership is strengthened by RIKEN’s extensive R&D infrastructure and imaging resources.
“Today’s Agreement with ZEISS, a corporation which has earned a high level of trust world-wide as a manufacturer of high-precision microscopes and optical instruments, represents a new kind of partnership that does not merely focus on separate research topics. I look forward to an environment in which our partners at ZEISS and researchers at RIKEN engage in free and open discussions, and for RIKEN Innovation to support both organizations in their strategic planning. I expect that this will lead to collaborative research activity of the highest level and the pioneering of new fields,” said Hiroshi Matsumoto, President of RIKEN.
“RIKEN Innovation was founded on September 5, 2019 as fully-owned subsidiary of RIKEN. Our purpose is to serve as an external entity to support RIKEN in promoting and facilitating industry-academia collaboration and to actively perform the work necessary for collaborative projects with industrial partners, which will put RIKEN’s research achievements to work for society. I am very happy for this opportunity to work with ZEISS, a highly respected corporation in the fields of optics and optoelectronics. We will work diligently so that this large-scale collaborative effort is successful, which will also serve to benefit society,” added Yoshihiro Aburatani, President, RIKEN Innovation.
As Japan’s largest and most comprehensive research organization, RIKEN conducts break-through research in broad range of science and technology including physics, engineering, chemistry, mathematics and information science, computational science, bioscience and medicine. Its R&D also contributes to Japan’s industrial development. RIKEN has 10 research locations in Japan including Wako, Kobe, Osaka, Tokyo, Harima and Yokohama. For more information go to http://www.riken.jp/
About RIKEN Innovation Co., Ltd.
Established on September 5, 2019, RIKEN Innovation is wholly owned by RIKEN, according to the new Japanese Law of Active Creation of Scientific Technology and Innovation. It is responsible with work related to collaborations between RIKEN and its industrial partners, with the mission of returning to society the fruits of research and innovation. For more information go to http://www.innovation-riken.jp
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 6.4 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2019).
Founded in 1846, ZEISS is is headquartered in Oberkochen, Germany. ZEISS is present in almost 50 countries with around 60 sales and service companies, 30 production sites and 25 development sites. The company employs over 31,000 professionals.
For press inquiries, please contact:
Phone: +49 7364 20-3242
SOURCE: ZEISS International